000 | 01345cam a2200289 4500 | ||
---|---|---|---|
020 | _a9283212762 | ||
035 | _a(Sirsi) a69673 | ||
060 | _aQV 268.5 2000IA | ||
111 | 2 |
_aIARC Working Group on the Evaluation of Carcinogenic Risks to Humans : Some Antiviral and Antineoplastic Agents and other Pharmaceutical Agents _d(1999: _cLyon, France) |
|
245 | 0 | 0 |
_aSome antiviral and antineoplastic agents and other pharmaceutical agents : _bviews and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, Lyon, 12-19 October 1999. |
260 |
_aLyon : _bInternational Agency for Research on Cancer, _c2000. |
||
300 | _a487 p. + cumulated index. | ||
440 | 0 |
_aIARC monographs on the evaluation of carcinogenic risks to humans ; _vv. 76 |
|
550 | _aWHODOC | ||
561 | _aWHO monograph | ||
596 | _a4 | ||
650 | 0 | 2 | _aCarcinogens. |
650 | 0 | 2 |
_aAntiviral agents _xtoxicity _xadverse effects. |
650 | 0 | 2 |
_aAntineoplastic agents _xtoxicity _xadverse effects. |
650 | 0 | 2 |
_aPharmaceutical preparations _xtoxicity _xadverse effects. |
650 | 0 | 2 |
_aDrug therapy _xadverse effects. |
650 | 0 | 2 |
_aNeoplasms _xchemically induced. |
690 | _aPharmaceuticals and Biologicals. | ||
710 | 2 | _aInternational Agency for Research on Cancer. | |
008 | s2000 1 0 eng | ||
942 |
_2NLM _cMONOGRAPH |
||
999 |
_c22949 _d22949 |